317 related articles for article (PubMed ID: 31576545)
1. Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans.
Olender J; Lee NH
Adv Exp Med Biol; 2019; 1164():119-139. PubMed ID: 31576545
[TBL] [Abstract][Full Text] [Related]
2. Targeting alternative splicing in prostate oncology.
Carling PJ; Elliott DJ; Robson CN; Leung HY; Rajan P
Discov Med; 2009 Aug; 8(41):74-80. PubMed ID: 19788872
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.
Wang BD; Ceniccola K; Hwang S; Andrawis R; Horvath A; Freedman JA; Olender J; Knapp S; Ching T; Garmire L; Patel V; Garcia-Blanco MA; Patierno SR; Lee NH
Nat Commun; 2017 Jun; 8():15921. PubMed ID: 28665395
[TBL] [Abstract][Full Text] [Related]
4. A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.
Olender J; Wang BD; Ching T; Garmire LX; Garofano K; Ji Y; Knox T; Latham P; Nguyen K; Rhim J; Lee NH
Mol Cancer Res; 2019 Oct; 17(10):2115-2125. PubMed ID: 31266816
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing and biological heterogeneity in prostate cancer.
Rajan P; Elliott DJ; Robson CN; Leung HY
Nat Rev Urol; 2009 Aug; 6(8):454-60. PubMed ID: 19657379
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Thorsen K; Sørensen KD; Brems-Eskildsen AS; Modin C; Gaustadnes M; Hein AM; Kruhøffer M; Laurberg S; Borre M; Wang K; Brunak S; Krainer AR; Tørring N; Dyrskjøt L; Andersen CL; Orntoft TF
Mol Cell Proteomics; 2008 Jul; 7(7):1214-24. PubMed ID: 18353764
[TBL] [Abstract][Full Text] [Related]
7. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.
Teslow EA; Bao B; Dyson G; Legendre C; Mitrea C; Sakr W; Carpten JD; Powell I; Bollig-Fischer A
Mol Oncol; 2018 Jun; 12(7):1138-1152. PubMed ID: 29741809
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and prostate cancer racial disparities among American men.
Chaudhary AK; O'Malley J; Kumar S; Inigo JR; Kumar R; Yadav N; Chandra D
Front Biosci (Schol Ed); 2017 Jan; 9(1):154-164. PubMed ID: 27814581
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: Alternatively spliced mRNA transcripts in tumor progression and their uses as therapeutic targets.
Calderon-Aparicio A; Wang BD
Int J Biochem Cell Biol; 2021 Dec; 141():106096. PubMed ID: 34653618
[TBL] [Abstract][Full Text] [Related]
10. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
11. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
[TBL] [Abstract][Full Text] [Related]
12. Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.
Marima R; Hull R; Mbeje M; Molefi T; Mathabe K; Elbagory AM; Demetriou D; Dlamini Z
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054814
[TBL] [Abstract][Full Text] [Related]
13. Age-related racial disparities in prostate cancer patients: A systematic review.
He T; Mullins CD
Ethn Health; 2017 Apr; 22(2):184-195. PubMed ID: 27706949
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
17. Alternative RNA splicing in tumour heterogeneity, plasticity and therapy.
Öther-Gee Pohl S; Myant KB
Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 35014671
[TBL] [Abstract][Full Text] [Related]
18. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans.
Jones J; Grizzle W; Wang H; Yates C
Biotech Histochem; 2013 Oct; 88(7):410-24. PubMed ID: 23901944
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities: disruptive genes in prostate carcinogenesis.
Singh S; Plaga A; Shukla GC
Front Biosci (Schol Ed); 2017 Jun; 9(2):244-253. PubMed ID: 28410117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
